ADVFN Logo
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

PFE Pfizer Inc

29.865
-0.275 (-0.91%)
最終更新日: 01:24:12
15分遅延
名称 銘柄コード 市場 種別
Pfizer Inc PFE NYSE 普通株式
  前日比 前日比 % 現在値 時刻
-0.275 -0.91% 29.865 01:24:12
始値 安値 高値 終値 前日終値
30.11 29.82 30.12 30.14
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2023/11/2200:00BWPfizer Invites Public to View and Listen to Webcast of..
2023/11/1712:33PRNUSPfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier..
2023/11/1708:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1708:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1708:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1518:45DJNPfizer to Stop Some Operations at Sandwich, UK Site; 500..
2023/11/1516:13DJNPfizer to Close UK Site With 500 Job losses, Sky News..
2023/11/0906:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0802:41DJNPfizer to Relocate 781 Workers as It Closes New Jersey..
2023/11/0707:40DJNPfizer to Lay Off 781 Workers in New Jersey
2023/11/0223:52BWPfizer Highlights Scientific Advances from Growing..
2023/11/0223:00BWPfizer Invites Public to View and Listen to Webcast of..
2023/11/0207:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0207:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0207:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0104:48DJNTrending: Pfizer 3Q Revenue Down 42%
2023/10/3121:04EDGAR2Form 8-K - Current report
2023/10/3120:41IHMARKETNEWSPfizer Swings to Q3 Adjusted Loss, Revenue Falls
2023/10/3120:24IHMARKETNEWSTuesday’s Wall Street Highlights: Pinterest, BP, Wolfspeed,..
2023/10/3119:45BWPfizer Reports Third-Quarter 2023 Results
2023/10/3021:45IHNWCan Diabetes, Weight-Loss Drugs Get Even Better?
2023/10/2805:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/10/2619:45BWPfizer and BioNTech Announce Positive Topline Data for..
2023/10/2606:29EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/10/2404:41DJNTrending: Roche to Buy Telavant From Roivant and Pfizer
2023/10/2320:18IHMARKETNEWSMonday’s Wall Street Highlights: Philips, Chevron,..
2023/10/2317:16DJNRoche to Buy Telavant From Roivant, Pfizer in Deal Worth Up..
2023/10/2314:50DJNRoche to Buy Telavant From Roivant Sciences and Pfizer in..
2023/10/2105:42DJNPfizer Says FDA Approves Penbraya Vaccine for Meningococcal..
2023/10/2104:35BWFDA Approves PENBRAYA™, the First and Only Vaccine for the..
2023/10/2020:22IHMARKETNEWSFriday’s Wall Street Highlights: SolarEdge, Intuitive..
2023/10/1905:27EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/10/1902:39DJNPfizer on Track for Lowest Close Since July 2020 -- Data..
2023/10/1720:37IHMARKETNEWSTuesday’s Wall Street Highlights: Snap, Ericsson, NetScout..
2023/10/1705:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1705:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1705:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1623:11DJNTrending: Pfizer Slashes Fiscal Year Guidance By $9 Billion
2023/10/1622:01IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
2023/10/1608:44PRNUSEverest Medicines' Licensing Partner Pfizer Announces U.S...
2023/10/1607:37PRNUSAstellas to Share New Data Across Hard-to-Treat Cancers..
2023/10/1607:05GLOBEArvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471)..
2023/10/1409:17DJNStocks to Watch: Pfizer, Moderna, Lululemon Athletica
2023/10/1408:24DJNPfizer Shares Fall 3.5% as Lower Demand for Covid-19..
2023/10/1406:40DJNPfizer Slashes Fiscal Year Guidance as It Lowers Revenue..
2023/10/1406:30EDGAR2Form 8-K - Current report
2023/10/1406:29DJNPfizer to Reverse $4.2 Billion In Revenue After Accepting..
2023/10/1405:30BWPfizer Amends U.S. Government Paxlovid Supply Agreement and..
2023/10/1322:00BWU.S. FDA Approves Pfizer’s VELSIPITY™ for Adults with..
2023/10/1304:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

ADVFNのサービスをご利用いただくには、 利用規約

Support: +44 (0) 203 8794 460 | support@advfn.com